Department of Surgery, Division of Endocrine & Minimally Invasive Surgery, Weill Cornell Medical College, New York-Presbyterian Hospital, 525 East 68th Street, K-836, New York, NY, 10065, USA.
Division of Biostatistics, Department of Population Health Sciences, Weill Cornell Medical College, New York-Presbyterian Hospital, New York, NY, USA.
Surg Endosc. 2022 Jul;36(7):5456-5466. doi: 10.1007/s00464-021-08888-y. Epub 2022 Jan 3.
Anti-reflux surgery (ARS) has known long-term complications, including dysphagia, bloat, and flatulence, among others. The factors affecting the development of post-operative dysphagia are poorly understood. We investigated the correlation of intra-operative esophagogastric junction (EGJ) characteristics and procedure type with post-operative dysphagia following ARS.
Robotic ARS was performed on 197 consecutive patients with pathologic reflux utilizing EndoFLIP™ technology. Intraoperative EGJ measurements including distensibility index (DI), cross-sectional area (CSA), and high-pressure zone (HPZ) length were collected. Dysphagia was assessed pre-operatively and at 3 months post-operatively.
The median pre-operative DI for all procedures was 2.6 (IQR 1.6-4.5) mm/mmHg. There was no difference in post-operative DI between procedures [Hill: 0.9 (IQR 0.7-1.1) mm/mmHg, Nissen: 1.0 (IQR 0.7-1.4) mm/mmHg, Toupet: 1.2 (IQR 0.8-1.5) mm/mmHg, Linx: 1.0 (IQR 0.7-1.2) mm/mmHg, p = 0.24], whereas post-operative HPZ length differed by augmentation type [Hill: 3 (IQR 2.8-3) cm, Nissen: 3.5 (IQR 3-3.5) cm, Toupet: 3 (IQR 2.5-3.5) cm, Linx: 2.5 (IQR 2.5-3) cm, p = 0.032]. Eighty-nine patients (45.2%) had pre-operative dysphagia. Thirty-two patients (27.6%) reported any dysphagia at their 3-month post-operative visit and 12 (10.3%) developed new or worsening post-operative dysphagia [Hill: 2/18 (11.1%), Nissen: 2/35 (5.7%), Toupet: 4/54 (7.4%), Linx: 4/9 (44.4%), p = 0.006]. The median pre-operative and post-operative DI of patients who developed new or worsening dysphagia was 2.0 (IQR 0.9-3.8) mm/mmHg and 1.2 (IQR 1.0-1.8) mm/mmHg, respectively, and that of those who did not was 2.5 (IQR 1.6-4.0) mm/mmHg and 1.0 (IQR 0.7-1.4) mm/mmHg (p = 0.21 and 0.16, respectively).
Post-operative DI was similar between procedures, and there was no correlation with new or worsening post-operative dysphagia. Linx placement was associated with higher rates of new or worsening post-operative dysphagia despite a shorter post-procedure HPZ length and similar post-operative DI when compared to other methods of LES augmentation.
抗反流手术(ARS)有已知的长期并发症,包括吞咽困难、腹胀和呃逆等。导致术后吞咽困难的因素尚未完全了解。我们研究了术中食管胃连接部(EGJ)特征和手术类型与 ARS 术后吞咽困难的相关性。
利用 EndoFLIP™ 技术对 197 例病理性反流患者进行机器人 ARS。术中收集食管胃连接部(EGJ)的可扩张性指数(DI)、横截面积(CSA)和高压区(HPZ)长度等指标。术前和术后 3 个月评估吞咽困难。
所有手术的术前 DI 中位数为 2.6(IQR 1.6-4.5)mm/mmHg。不同手术方式之间术后 DI 无差异[Hill:0.9(IQR 0.7-1.1)mm/mmHg,Nissen:1.0(IQR 0.7-1.4)mm/mmHg,Toupet:1.2(IQR 0.8-1.5)mm/mmHg,Linx:1.0(IQR 0.7-1.2)mm/mmHg,p=0.24],但术后 HPZ 长度因增强类型而异[Hill:3(IQR 2.8-3)cm,Nissen:3.5(IQR 3-3.5)cm,Toupet:3(IQR 2.5-3.5)cm,Linx:2.5(IQR 2.5-3)cm,p=0.032]。89 例患者(45.2%)术前有吞咽困难。32 例(27.6%)患者在术后 3 个月随访时报告有任何吞咽困难,12 例(10.3%)出现新的或加重的术后吞咽困难[Hill:2/18(11.1%),Nissen:2/35(5.7%),Toupet:4/54(7.4%),Linx:4/9(44.4%),p=0.006]。出现新的或加重的吞咽困难的患者术前和术后 DI 的中位数分别为 2.0(IQR 0.9-3.8)mm/mmHg和 1.2(IQR 1.0-1.8)mm/mmHg,而无吞咽困难的患者分别为 2.5(IQR 1.6-4.0)mm/mmHg和 1.0(IQR 0.7-1.4)mm/mmHg(p=0.21 和 0.16)。
不同手术方式之间的术后 DI 相似,且与新的或加重的术后吞咽困难无关。与其他 LES 增强方法相比,尽管 Linx 置入术后 HPZ 长度较短,术后 DI 相似,但与新的或加重的术后吞咽困难发生率较高相关。